Pelvic health · 5 min read
Vaginal dryness treatments: from moisturizers to vaginal estrogen
Vaginal dryness treatments compared: lubricants, moisturizers, vaginal estrogen, DHEA, and ospemifene, with what the trials show and where to start.
Vaginal dryness in perimenopause and after menopause is treatable, and most women can find something that works. Start with a lubricant for sex and a regular vaginal moisturizer if symptoms are mild; move to low-dose vaginal estrogen, vaginal DHEA, or oral ospemifene if dryness is moderate to severe or does not improve. Low-dose vaginal estrogen has the strongest evidence and a reassuring safety record.
Why dryness happens
Estrogen keeps the vaginal lining thick, elastic, and moist. As levels fall, the lining thins and produces less fluid. Dryness is one part of genitourinary syndrome of menopause (GSM), which can also cause burning, pain with sex, and urinary symptoms.
It often starts before periods stop. In the SWAN study of 2,435 women followed for up to 17 years, dryness was reported by 19.4% at ages 42 to 53 and by 34.0% at ages 57 to 69. Advancing menopausal stage, surgical menopause, and anxiety were linked to developing dryness, and higher natural estradiol levels were protective. Dryness was in turn linked to later pain during sex.
Breastfeeding, aromatase inhibitors, and cancer treatments that stop the ovaries can cause the same changes.
Over-the-counter options
Lubricants reduce friction during sex. They come in water-based, silicone-based, and oil-based forms; oil-based products can weaken latex condoms.
Vaginal moisturizers are bioadhesive gels or inserts used on a schedule, usually two to three times a week, whether or not you are having sex. They aim to ease day-to-day dryness.
The Menopause Society grades both as first-line therapy (Level A), and the AUA/SUFU/AUGS guideline says clinicians should recommend them, alone or alongside other treatments. Composition matters: the World Health Organization recommends osmolality below 1,200 mOsm/kg, because many water-based products are concentrated enough to irritate tissue. Our guide to vaginal moisturizers and lubricants explains how to choose.
How well do they work? In the largest trial, 302 postmenopausal women with moderate to severe symptoms used a vaginal estradiol tablet, a moisturizer, or placebo for 12 weeks. All three groups improved substantially and similarly. The likely explanation is that the placebo gel was itself lubricating, so the trial shows that regular use of a bland gel helps, not that nothing works.
Prescription options
Low-dose vaginal estrogen comes as a cream, a vaginal tablet or insert, or a ring. Creams, tablets, and inserts are usually used daily for about two weeks, then two to three times a week; the ring is replaced every three months. The AUA guideline makes a strong recommendation that clinicians offer it for dryness, irritation, and pain with sex. In one trial it cited, 81% of women on vaginal estrogen had their dryness resolve at 36 weeks, compared with 17% with no treatment.
A 2016 Cochrane review of 30 trials (6,235 women) found no difference in effectiveness between the forms. Cream was linked to more thickening of the uterine lining than the ring, possibly because higher doses were used. Pick the form that suits you: creams can also soothe the vulva, while tablets, inserts, and the ring are less messy and fixed-dose.
Vaginal DHEA (prasterone) is a daily vaginal insert that the vaginal cells convert to estrogens and androgens. Four trials with 1,472 women showed improved dryness and pain with sex compared with placebo. Vaginal discharge is the most common side effect.
Ospemifene is a daily pill that acts like estrogen on vaginal tissue. The AUA guideline rates the evidence as weaker (a conditional recommendation) and notes small increases in hot flashes and vaginal discharge. Its label carries a boxed warning covering endometrial cancer, stroke, and blood clots. It suits women who prefer a pill or cannot use a vaginal product.
Systemic hormone therapy helps when hot flashes are also a problem. Some women still need a vaginal product on top; the AUA guideline supports adding vaginal estrogen or DHEA.
| Option | Prescription? | How often | Evidence | Main drawbacks |
|---|---|---|---|---|
| Lubricant | No | At sex | First-line (Level A) | Short-lived; some irritate |
| Moisturizer | No | 2 to 3 times a week | First-line (Level A) | Trial benefit similar to placebo gel |
| Vaginal estrogen | Yes | 2 to 3 times a week after a loading phase; ring every 3 months | Strongest | Cost varies by insurance |
| Vaginal DHEA | Yes | Daily | Moderate | Discharge; daily use |
| Ospemifene | Yes | Daily pill | Conditional | Hot flashes; boxed warning |
What does not help, or is unproven
- Lasers and radiofrequency devices: the AUA guideline says evidence does not support them for dryness or pain with sex.
- Supplements and herbal products: a one-year trial of black cohosh, a multibotanical, and soy found no change in vaginal dryness.
- Hyaluronic acid products: small trials found them about as helpful as placebo or vaginal estrogen, with no proof they beat other moisturizers. They are a reasonable choice, not a required one.
- Douches, scented washes, and harsh cleansers: the AUA guideline advises avoiding irritants.
Timing and safety
Improvement usually starts within a few weeks, but treatment for 12 weeks may be needed for full benefit. Symptoms return when treatment stops, so most women continue long term.
Low-dose vaginal estrogen keeps blood estrogen levels generally within the postmenopausal range. No progestogen is needed, and routine endometrial monitoring is not recommended for low-risk women. Any spotting or bleeding after menopause needs evaluation. The FDA’s November 2025 request removed the cardiovascular, breast cancer, and dementia language from the boxed warning on these products, though inserts printed earlier may still carry the old wording.
If you have had breast cancer, talk with your oncologist; the options and trade-offs are covered in non-hormonal options for breast cancer survivors.
When to see a clinician
- Dryness or pain with sex that persists after several weeks of over-the-counter products
- Bleeding after sex or after menopause
- Itching, sores, white patches, or unusual discharge, which can signal infection or a skin condition
- Burning with urination or repeated UTIs
How to bring it up
Say it directly: “I have vaginal dryness that is affecting my comfort and my sex life. What are my options, including vaginal estrogen?” Mention what you have tried and for how long. An OB-GYN or a menopause specialist can examine you, rule out other causes, and help you pick a treatment.
Frequently asked questions
Should I start with a moisturizer or go straight to vaginal estrogen?
It depends on how much the dryness bothers you. For mild symptoms, a moisturizer used two to three times a week plus a lubricant for sex is a reasonable first step. For moderate to severe symptoms, or if over-the-counter products are not enough after several weeks, the AUA/SUFU/AUGS guideline says clinicians should offer low-dose vaginal estrogen. Many women use a prescription treatment and a lubricant together.
Is it safe to use vaginal estrogen for years?
Randomized trials last up to about a year, but large observational studies that followed users much longer are reassuring, including a Nurses' Health Study cohort of about 54,000 women that found no increase in heart disease or cancer. A progestogen is not needed with low-dose vaginal estrogen. Report any vaginal bleeding after menopause so it can be checked.
Why does the vaginal estrogen package have a scary warning?
For years, low-dose vaginal estrogen carried the same boxed warning as systemic hormone therapy. In November 2025 the FDA asked manufacturers to remove the cardiovascular, breast cancer, and dementia language from the boxed warning of all menopausal hormone products, and to keep the endometrial cancer warning only on systemic estrogen-alone products. Because labels are updated product by product, an insert printed before the change may still show the old warning.
Do supplements or herbal products help dryness?
The evidence says no. In a one-year randomized trial of 351 women, black cohosh, a multibotanical supplement, and soy did not change vaginal dryness, and the AUA guideline says evidence does not support alternative supplements for these symptoms.
Sources
- The NAMS 2020 GSM Position Statement Editorial Panel. The 2020 genitourinary syndrome of menopause position statement of The North American Menopause Society. Menopause, 2020
- American Urological Association. Genitourinary Syndrome of Menopause: AUA/SUFU/AUGS Guideline (2025)
- Lethaby A, et al. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database of Systematic Reviews, 2016
- Mitchell CM, et al. Efficacy of Vaginal Estradiol or Vaginal Moisturizer vs Placebo for Treating Postmenopausal Vulvovaginal Symptoms: A Randomized Clinical Trial. JAMA Internal Medicine, 2018
- Waetjen LE, et al. Factors associated with developing vaginal dryness symptoms in women transitioning through menopause: a longitudinal study. Menopause, 2018
- FDA. FDA Requests Labeling Changes Related to Safety Information to Clarify the Benefit/Risk Considerations for Menopausal Hormone Therapies, 2025